August 15, 2017 04:20 PM EDT
Pharma

As Trump lash­es out at Fra­zier again, J&J's Alex Gorsky says he's not aban­don­ing pres­i­den­t's coun­cil

John Carroll

Editor & Founder

See the lat­est up­date here.

J&J CEO Alex Gorsky isn’t join­ing any ex­o­dus off of the pres­i­dent’s man­u­fac­tur­ing coun­cil. And he of­fered his rea­sons …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Bris­tol My­ers, Ky­owa Kirin dis­close lay­offs

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

Eye­Point shares more mid-stage da­ta for ther­a­py try­ing to com­pete with Re­gen­eron's Eylea

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

No­vo Nordisk is feel­ing the com­pe­ti­tion from com­pound­ed GLP-1s, ex­ec says

GSK de­fi­ant against vac­cine chal­lenges, will pri­or­i­tize oth­er growth ar­eas

A service from the Financial Times